Stocks & Investing
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
Wed, January 24, 2024
[ 12:00 AM ] - WOPRAI
Wed, November 29, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 3, 2023
[ 12:00 AM ] - WOPRAI
Wed, August 2, 2023
[ 12:00 AM ] - WOPRAI
Tue, July 25, 2023
[ 12:00 AM ] - WOPRAI
Mon, July 24, 2023
[ 12:00 AM ] - WOPRAI
Thu, July 20, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 26, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 22, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Thu, January 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, December 30, 2022
[ 12:00 AM ] - WOPRAI
Tue, December 20, 2022
[ 12:00 AM ] - WOPRAI
Thu, December 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, October 21, 2022
[ 12:00 AM ] - WOPRAI
Wed, September 28, 2022
[ 12:00 AM ] - WOPRAI
Tue, May 24, 2022
[ 12:00 AM ] - WOPRAI
Mon, May 9, 2022
[ 12:00 AM ] - WOPRAI
Wed, December 15, 2021
[ 12:00 AM ] - WOPRAI
Mon, November 15, 2021
[ 12:00 AM ] - WOPRAI
Tue, October 13, 2020 Corinne Jenkins Maintained (TGTX) at Hold with Increased Target to $20 on, Aug 7th, 2024
Corinne Jenkins of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Hold with Increased Target from $18 to $20 on, Aug 7th, 2024.
Corinne has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Corinne
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $49 on, Tuesday, August 6th, 2024
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $40 on, Thursday, May 2nd, 2024
- Eric Joseph of "JP Morgan" Reiterated at Buy and Held Target at $25 on, Thursday, April 18th, 2024
